App-Quantinova.ai

Contrasting Influences of Renal Function on Blood Pressure and HbA1c Reductions With Empagliflozin in Patients With Type 2 Diabetes and Hypertension

Mark Cooper - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Chronic kidney disease

BI-10773

Impact of Diastolic Dysfunction on Outcomes of Patients With Aortic Stenosis

Abdellaziz Dahou - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Chronic obstructive pulmonary disease

N/A

Estimation of Stroke Volume and Aortic Valve Area in Patients With Aortic Stenosis: A Comparison of Doppler-Echocardiography and Cardiac Magnetic Resonance

Florent Le Ven - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Aortic stenosis

N/A

Changes in Carotid Wall Morphology and Plaque Composition in Patients With Established Vascular Disease and Treated With Intensive Lipid Therapy in the AIM-HIGH Study

Thomas Hatsukami - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Niacor

Exosomes Mediate Heat Shock Protein 27 Athero-Protective Signalling

Yuan Zhang - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Alkaline phosphatase

Discovery of a Novel Approach for Modulating Angiogenesis: The Interaction Between Heat Shock Protein 27 and ATP5A1 Promotes Endothelial Cell Dynamics

Chunhua Shi - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

angiostatin

ICD Lead Performance in Athletes: Results of a Prospective Multinational Registry

Renee M Sullivan - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Structural Heart Disease

N/A

Reliable Estimation of Left Ventricular Ejection Fraction Using High Resolution Surface Electrocardiography

Tim Burton - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Post-myocardial infarction

N/A

The Cost-Effectiveness of Apixaban versus Warfarin in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Study Group

Shubin Sheng - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

apixaban

Risk Factors Associated With Progression of Carotid Wall Volume and Plaque Lipid Content in Patients With Established Vascular Disease and Treated With Intensive Lipid Therapy in the AIM-HIGH Study

Kevin D O'Brien - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Niacor

Impact of Patient Transfers on Outcome Evaluations Following Acute Myocardial Infarction

Mona Izadnegahdar - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Increased Circulating Levels of MiRNA-21 Mirrors Disease Activity in Rats With Monocrotaline-Induced Pulmonary Arterial Hypertension

Yupu Deng - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

Monocrotaline

Diabetes Inhibits Cardiac Stem Cell-Mediated Cardiac Repair Through the Accumulation of Reactive Dicarbonyls

Nicholas Latham - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Myocardial infarction

Streptozotocin

Use of Thienopyridine Prior to Presentation for Acute Coronary Syndromes and Association With Safety and Efficacy of Vorapaxar: Insights From the TRACER Study

Giuseppe Ambrosio - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute Coronary Syndromes

Vorapaxar

The Impact of the Publication of Cardiovascular Safety Signals on the Prescribing of Varenicline: an Interrupted Time-Series Analysis

Maria Eberg - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Champix

Abnormal Immunomodulatory Function of Mesenchymal Stem Cells From Elderly Patients With Coronary Artery Disease: A Novel Pro-Atherogenic Mechanism?

Dominique Shum-Tim - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Strain-specific Differences in the Response to SU5416 in the Rat Model of Severe Pulmonary Arterial Hypertension

Yupu Deng - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

SU5416

Information Delivery Affects Patient- Attitudes Toward Devices More Than Toward Medicines to Treat Heart Failure

Garrick C Stewart - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Congestive heart failure

N/A

A Meta-Synthesis on Usefulness of Stress Reduction with Meditation in the Prevention and Treatment of Cardiovascular Disease

Amy Ruff - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronary Artery Disease

N/A

An Antisense Inhibitor of Apolipoprotein C-III Significantly Decreases Nonesterified Fatty Acid Levels in Severe Hypertriglyceridemic Patients

Diane Brisson - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Dyslipidemia

ISIS-APOCIIIRx

Filters

28841 Abstracts